UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| 1 |
Strategy Inc
MSTR
|
+$1.17B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$851M |
| 3 |
Boeing
BA
|
+$833M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Advanced Micro Devices
AMD
|
+$676M |
Top Sells
| 1 |
UnitedHealth
UNH
|
+$499M |
| 2 |
Unity
U
|
+$159M |
| 3 |
Amneal Pharmaceuticals
AMRX
|
+$159M |
| 4 |
Eli Lilly
LLY
|
+$150M |
| 5 |
Invesco BulletShares 2025 Corporate Bond ETF
BSCP
|
+$126M |
Sector Composition
| 1 | Technology | 22.46% |
| 2 | Financials | 10.98% |
| 3 | Consumer Discretionary | 8.5% |
| 4 | Healthcare | 7.57% |
| 5 | Industrials | 7.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
5126
Mediaco Holding
MDIA
$69.2M
| $244K | ﹤0.01% |
214,010
+213,175
| +25,530% | +$243K |
|
5127
Acumen Pharmaceuticals
ABOS
$76.3M
| $243K | ﹤0.01% |
141,492
+118,741
| +522% | +$204K |
|
5128
Global X Video Games & Esports ETF
HERO
$173M
| $243K | ﹤0.01% |
10,335
+3,361
| +48% | +$78.9K |
|
5129
Personalis
PSNL
$541M
| $242K | ﹤0.01% |
41,927
+34,850
| +492% | +$201K |
|
5130
BlackRock MuniVest Fund II
MVT
$227M
| $242K | ﹤0.01% |
22,921
-1
| -0% | -$11 |
|
|
ECF
5131
Ellsworth Growth & Income Fund
ECF
$161M
| $241K | ﹤0.01% |
24,915
+1,249
| +5% | +$12.1K |
|
5132
FT Energy Income Partners Strategy ETF
EIPX
$383M
| $241K | ﹤0.01% |
9,843
-44
| -0.4% | -$1.08K |
|
5133
FlexShares Global Quality Real Estate Index Fund
GQRE
$375M
| $241K | ﹤0.01% |
4,230
-3
| -0.1% | -$171 |
|
5134
Tile Shop Holdings
TTSH
$294M
| $241K | ﹤0.01% |
34,758
+16,891
| +95% | +$117K |
|
5135
Full House Resorts
FLL
$125M
| $240K | ﹤0.01% |
58,727
+37,526
| +177% | +$153K |
|
5136
American Well
AMWL
$104M
| $239K | ﹤0.01% |
32,993
+30,767
| +1,382% | +$223K |
|
5137
RH Tactical Outlook ETF
RHTX
$8.29M
| $239K | ﹤0.01% |
14,724
+7,189
| +95% | +$117K |
|
5138
Xilio Therapeutics
XLO
$40.4M
| $238K | ﹤0.01% |
249,401
+233,668
| +1,485% | +$223K |
|
|
QVCGA
5139
QVC Group Inc Series A
QVCGA
$115M
| $238K | ﹤0.01% |
14,411
+5,145
| +56% | +$84.9K |
|
5140
National Research Corp
NRC
$341M
| $238K | ﹤0.01% |
13,476
+4,020
| +43% | +$70.9K |
|
5141
Trinseo
TSE
$92M
| $238K | ﹤0.01% |
46,599
+40,843
| +710% | +$208K |
|
5142
Compass Therapeutics
CMPX
$582M
| $237K | ﹤0.01% |
163,656
+98,256
| +150% | +$142K |
|
5143
FT Vest US Equity Moderate Buffer ETF February
GFEB
$356M
| $237K | ﹤0.01% |
6,347
-4,813
| -43% | -$180K |
|
5144
RAPT Therapeutics
RAPT
$328M
| $236K | ﹤0.01% |
18,709
+15,103
| +419% | +$191K |
|
|
NAGE
5145
Niagen Bioscience
NAGE
$786M
| $236K | ﹤0.01% |
44,473
-14,416
| -24% | -$76.5K |
|
5146
Roundhill Sports Betting & iGaming ETF
BETZ
$82.9M
| $235K | ﹤0.01% |
12,411
+11,716
| +1,686% | +$222K |
|
5147
AN2 Therapeutics
ANTX
$36.1M
| $235K | ﹤0.01% |
+170,292
| New | +$235K |
|
5148
Fidelity Small-Mid Multifactor ETF
FSMD
$1.72B
| $235K | ﹤0.01% |
5,699
+4,269
| +299% | +$176K |
|
5149
Fidelity Enhanced Large Cap Growth ETF
FELG
$4.44B
| $234K | ﹤0.01% |
6,630
-1,829
| -22% | -$64.7K |
|
5150
Day Hagan/Ned Davis Research Smart Sector ETF
SSUS
$569M
| $234K | ﹤0.01% |
5,555
-2,375
| -30% | -$99.9K |
|